Recommendations | LoE | CoR (%) |
---|---|---|
1. Comprehensive project management | ||
Key leaders; involvement of stakeholders | C | 100 |
Collection of PBM-related metrics | C | 90 |
2. Education program | ||
Education initiatives; standard operating procedures, clinical protocols, visual aids, checklists; algorithms | C | 100 |
Massive hemorrhage protocols; coagulation and transfusion algorithms | C | 100 |
Online PBM e-learning course | C | 100 |
Education at medical schools and hospital level | C | 100 |
3. Diagnosis and treatment of preoperative anemia | ||
Preoperative screening, diagnosis, and treatment of anemia | B | 100 |
Intravenous iron if oral iron is not tolerated or if surgery <4–6 weeks | B | 100 |
Erythropoiesis-stimulating agents if nutritional deficiencies have been ruled out, corrected, or both | B | 100 |
Elective surgery should be postponed until preoperative anemia has been classified and treated, if possible | C | 100 |
4. Reduction of iatrogenic diagnostic-/surgery-related blood loss | ||
Avoiding unnecessary laboratory tests, lower frequency of sampling, using the smallest collection tube size | C | 100 |
Closed in-line flush blood sampling devices for arterial (and central) lines | B | 100 |
Appropriate cessation strategies for anticoagulation and antiplatelet therapy | C | 100 |
Intraoperative approaches (meticulous hemostasis, minimally invasive surgery, laparoscopic surgery, diathermy dissection, physicians’ mindfulness regarding limiting blood loss, topical hemostatic agents) | B | 100 |
Coagulation algorithm (preoperative assessment, ensuring basic conditions for hemostasis, reversal of anticoagulants, point-of-care diagnostics, optimized coagulation management, use of clotting factor concentrates) | B | 100 |
Tranexamic acid | A | 100 |
Autologous blood cell recovery (cell salvage) | A | 100 |
5. Optimal blood component use with patient-centered clinical decision support | ||
Physician order entry with clinical decision support | B | 100 |
Patient’s informed consent prior transfusion; hand-written/computer-generated forms with detailed outline of transfusion benefits, risks, and alternatives; information in discharge summary; patient’s own preferences | C | 80 |